GGrantIndex
Sort

53,477 grants matching addiction

Clinical Relevance of Stress Neuroadaptation in Tobacco Dependence

$439,581
John J. Curtin · University Of Wisconsin-Madison · R01 · FY2015 · DA

Primary sensory neuron-targeted block of Cav3.2 for treatment of chronic neuropathic pain

$439,579
Hongwei Yu · Medical College Of Wisconsin · R33 · FY2022 · NS

Impact of a reduced nicotine standard on young adult appeal for menthol and non-menthol cigarettes

$439,574
Amy M Cohn · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · DA

Inflammatory and Dysregulated Repair Responses to Inhaled Nicotine

$439,573
Irfan Rahman · University Of Rochester · R01 · FY2019 · HL

How does Motivational Interviewing Work? Mechanisms of Action in Project CHOICES

$439,569
Karen S Ingersoll · University Of Virginia · R01 · FY2009 · AA

Nicotine flux, a potentially powerful tool for regulating nicotine delivery from electronic cigarettes: significance of nicotine flux to the rate of nicotine delivery and subjective effects

$439,476
Soha Talih · American University Of Beirut · R01 · FY2024 · DA

Human Behavioral Pharmacology of Substance Abuse

$439,461
George Bigelow · Johns Hopkins University · T32 · FY2012 · DA

Role of heat shock transcription factors (HSFs) in hematological malignancies

$439,457
Nahid F Mivechi · Augusta University · R01 · FY2024 · CA

Regulation of Mitochondrial Metabolism by Tyr-phosphorylated ATP Synthase Alpha-Subunit and its Therapeutic Implications in Prostate Cancer

$439,433
Nupam P Mahajan · Washington University · R01 · FY2024 · CA

RESEARCH EDUCATION PROGRAM ON COMPUTATIONAL AND STATISTICAL TOOL DEVELOPMENT FOR ADDICTION GENETICS

$439,406
Pamela Ann Madden · Washington University · R25 · FY2017 · DA

The Biological Basis of Alcohol-and Smoking-Induced Brain Injury

$439,379
Dieter J Meyerhoff · Northern California Institute/Res/Edu · R01 · FY2013 · AA

Developing and testing health warning labels on the ENDS device

$439,376
Wasim Maziak · Florida International University · R01 · FY2025 · DA

Cell-targeted glutamine antagonists as a novel therapy for lymphoma

$439,350
Barbara Stauch Slusher · Johns Hopkins University · R01 · FY2019 · CA

Targeting TERT in Melanoma

$439,320
Jessie Villanueva · Wistar Institute · R01 · FY2018 · CA

Effects of early-life neglect and cocaine use on PTSD-like behaviors

$439,290
James T. Porter · Ponce School Of Medicine · U54 · FY2021 · MD

Brain mechanisms of reducing polysubstance use following a novel body-mind intervention

$439,256
Yiyuan Tang · Texas Tech University · R61 · FY2019 · AT

Meta-analysis of Individual Patient Data for PTSD/AODs

$439,238
Antonio A. Morgan-Lopez · Research Triangle Institute · R01 · FY2021 · AA

Cohort Study of Opioids, Pain, and Safety in an era of Changing Policy (COPING)

$439,218
Phillip O Coffin · Public Health Foundation Enterprises · R01 · FY2019 · DA

Towards a Wearable Alcohol Biosensor: Examining the Accuracy of BAC Estimates from New-Generation Transdermal Technology using Large-Scale Human Testing and Machine Learning Algorithms

$439,213
Catharine Fairbairn · University Of Illinois At Urbana-Champaign · R01 · FY2023 · AA

Enhancing efficacy of vaccines for substance abuse through polymer-assisted delivery of immunomodulators

$439,201
Marco Pravetoni · Hennepin Healthcare Research Institute · R01 · FY2016 · DA

Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer

$439,200
Christopher Vakoc · Cold Spring Harbor Laboratory · U01 · FY2020 · CA

Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer

$439,200
Christopher Vakoc · Cold Spring Harbor Laboratory · U01 · FY2019 · CA

Exploiting POU2F3 addiction in the tuft cell variant of small cell lung cancer

$439,200
Christopher Vakoc · Cold Spring Harbor Laboratory · U01 · FY2021 · CA

Targeting TERT in Melanoma

$439,183
Jessie Villanueva · Wistar Institute · R01 · FY2017 · CA

Deconvoluting Dopaminergic Neuronal-Glial Interactions in the Striatum

$439,180
Amanda Maria Brown · Johns Hopkins University · R21 · FY2025 · DA